Cancer Medicine 12, 59085925
METABOLIC COPPER DISTURBANCE IN WILSON DISEASE The metabolic pathways underlying Wilson disease remain poorly understood, partly because the liver is a cryptic organ that tends to conceal metabolic disturbances, limiting insight unless specific biomarkers are released into the bloodstream for analysis by physicians and scientists [27]
doi: 10.1016/J.FOCHX.2024.101118 85
As with other GLP-1 medicines, people with: A history of severe gastrointestinal disease Pancreatitis Significant kidney or liver issues should only use GLP-1 treatments under close clinical monitoring
Tuy nhin, vi mt s hng dn c bn, bn c th d dng to ra i mi hon ho m khng gp nhiu rc ri
The indicates a downregulation of the corresponding target by the specific amino acid, whereas the indicates an upregulation